Adaptive Biotechnologies

Translates a scale and precision of the adaptive immune system into products to diagnose and treat disease.

Launch date

2009

Employees

501-1000 people

Market cap

Net debt

-

Enterprise valuation

$196m (Public information from May 2024)

Seattle Washington (HQ)

http://adaptivebiotech.com

https://twitter.com/adaptivebiotech http://www.facebook.com/pages/Adaptive-Biotechnologies/125974454184631 https://www.linkedin.com/company/adaptive-biotechnologies-corp-

Deals in current and previous year:

Sequenta

No columns specified